American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Investing

GE Vernova stock is expensive: is GEV still a good buy?

by admin January 15, 2025
January 15, 2025
GE Vernova stock is expensive: is GEV still a good buy?

GE Vernova stock price soared to a record high this week after a positive statement from Bank of America analysts who boosted their outlook. GEV soared to a high of $383, making it one of the best-performing spin-offs as the stock has soared by 235% from its lowest level in 2024, bringing its market cap to over $101 billion. So, can the overvalued company maintain its momentum?

Analysts are upbeat about GEV

GE Vernova is a large industrial company in the energy industry that emerged from General Electric. It became an independent company after GE decided to separate into three separately traded company. 

Today, GE Aerospace has gained a market cap of $191 billion, while GE Healthcare is valued at almost $40 billion. That brings the total market cap of the three companies to $332 billion, much higher than when they were part of a conglomerate. 

Analysts are upbeat about GE Vernova’s outlook, as energy demand continues to rise due to the artificial intelligence industry. In a note on Tuesday, analysts at Bank of America boosted the stock outlook from $386 to $415, citing the rising demand for gas turbines.

Other analysts are still bullish about the company, with those from JPMorgan, Wells Fargo, Jefferies, and Goldman Sachs having a bullish outlook.

This optimism is mostly because of the ambitious targets the company has set about its future. The company expects its annual revenue to grow to $48 billion in 2028 from about $35 billion in 2024 and $37 billion in 2025. 

It also expects its operating margin to move from about 6% in 2024 to over 14% in 2028. As such, if it manages to hit its targets, it means that its EBITDA will be about $6.72 billion by then.

Read more: GE Vernova stock soared to a record high: brace for a pullback

Valuation concerns remain

The main concern among most analysts is that its valuation has become stretched this year. Its stock price of $382 is higher than the median estimate of Wall Street analysts at $368. That is a sign that it has moved above the consensus estimate.

GE Vernova’s current valuation metrics paint it as a fast-growing company. Using the estimated EBITDA figure of $6.7 billion, investors are giving it a 2028 price-to-EBITDA ratio of 15, which is highly extreme.

Data compiled by SeekingAlpha shows that GE Vernova’s forward P/E ratio is 55.80, and its trailing figure is 79. These figures are both higher than the sector median of 22 and 23, respectively. These are huge numbers because fast-growing and high-margin companies like Microsoft and NVIDIA have smaller metrics than them.

They are also highly extreme because of the cyclical nature of the energy industry, especially wind. This is notable because interest rates and inflation are expected to remain higher for longer, impacting power infrastructure.

GE Vernova stock price analysis

GEV stock chart | Source: TradingView 

The daily chart reveals that the GEV share price surged from a low of 114.37p in March last year to $380 today. It moved above the crucial resistance point at $356, its highest level on November 21st. By moving above that level, the stock invalidated the double-top pattern that was forming. 

The stock has remained above all moving averages, while the Relative Strength Index (RSI) has moved close to the overbought point at 70. Therefore, the GEV stock price will likely continue rising as bulls target the resistance level at $400. It will then drop sharply amid profit-taking, potentially after its January 22 earnings. 

The post GE Vernova stock is expensive: is GEV still a good buy? appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
‘Winning the chip race’: what US semiconductor industry wants from the Trump administration
next post
Barclays share price forms risky patterns ahead of earnings season

Related Posts

Biotech Market Update: Q1 2024 in Review

April 19, 2024

​Tech 5: S&P 500 Achieves Record Close, Australian...

February 13, 2024

Pi Network price prediction for 2025 to 2026:...

February 21, 2025

Adrian Day: “Extremely Rare” Gold Stock Opportunity Won’t...

July 19, 2024

Fortune Minerals Announces Government of Canada Funding for...

May 17, 2024

Colgate-Palmolive stock analysis: overvalued ahead of earnings

January 30, 2025

DEA Submits Proposal to Reschedule Cannabis, Stocks Rally

May 2, 2024

A $280 billion question: Is it worth saving...

September 14, 2024

Oil and Gas Price Update: Q1 2024 in...

May 1, 2024

Cardiex Completes HEARTsense Wearable Study and Secures US...

April 3, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Why Asia is quietly turning its back on US dollar

      May 11, 2025
    • President Trump floats 80% tariff on Chinese goods ahead of key trade talks

      May 11, 2025
    • UK’s Crown Estate clears offshore wind expansion to raise energy output

      May 11, 2025
    • What extended conflict between India and Pakistan could cost their economies

      May 11, 2025
    • CoreWeave eyes $1.5B bond raise to ease debt load following lacklustre IPO: report

      May 10, 2025

    Categories

    • Business (2,842)
    • Investing (2,380)
    • Latest News (1,984)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved